Josep M. Grinyó «We want to establish our protein as a new therapy for autoimmune diseases»

At the Bosch i Gimpera Foundation we connect university
and business to transfer innovation to society

What we do

Contract Research

We provide customized research services for companies

Business Creation

We promote innovative new companies

Technologies, materials, and licences

We commercialize the technologies developed by researchers to make them available to companies

Who can benefit from our services

Researchers

We help you so that your research has an impact on society

Companies

We propose to improve the competitiveness of your business through innovation

Investors and mentors

We provide you with opportunities as an investor, business angel, or mentor

Results

768

companies and institutions innovate with us

32.67M€

for the UB in contracted revenue

1,948

active projects

The FBG in Figures >

Success Stories

DAPCOM Data Services develops a program that compresses massive data, from stars to the seabed

Virtual simulations to learn how to speak in public

Chiara, an application developed using UB technology allows you to work on your speaking skills autonomously and without teachers

A website to warn of the interactions derived from combining cardiovascular drugs with certain types of food

The professionals can search by therapeutic or drug group, food, medicinal plant or supplement

More Success Stories >

News

New advances in the treatment of advanced lung cancer

The University of Barcelona (UB) and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of...

Recreation of surgical interventions in Civil War front

During the Spanish Civil War, the units in Loussa mine, in el Molar (Priorat), held a campaign hospital. Now, the Research Group...

Josep M. Grinyó «We want to establish our protein as a new therapy for autoimmune diseases»

The team led by Dr. Grinyó, a researcher of the Faculty of Medicine and Health Sciences of the University of...

More news >